AIMM- Acipimox in Mitochondrial Myopathy
The AIMM (Acipimox in Mitochondrial Myopathy) trial is a clinical trial to determine whether a drug, acipimox, can be used to improve muscle symptoms in patients with mitochondrial myopathy (muscle…
The AIMM (Acipimox in Mitochondrial Myopathy) trial is a clinical trial to determine whether a drug, acipimox, can be used to improve muscle symptoms in patients with mitochondrial myopathy (muscle…
Earlier this week, the Wellcome Centre for Mitochondrial Research (WCMR) at Newcastle University announced its search to appoint a new Director as successor to Professor Sir Doug Turnbull. This is…